InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: mrmainstreet post# 112337

Tuesday, 08/15/2017 5:45:22 PM

Tuesday, August 15, 2017 5:45:22 PM

Post# of 430582
MMstreet...

The interim decision has very little predictive value when considering the results...The trial was designed to go to 1600 plus events and no one, no one, should conclude it is a failure because it's following the designed path...

Comments like the world is going to end or the results are going to be poor are just non sense or guys whose bets are that the PPS is going lower...

I have never seen a drug or anything in medicine more impressive than Vascepa..and I am a Harvard Med school grad, worked on the artificial heart project for two years,, and served as a clinical adviser to a group at Harvard Med studying novel ways to control inflammation.

I have prescribed the drug to over 100 patients and have seen first hand on how effective it is in controlling inflammation. On the skin, cutaneous tissues...The inflammatory system is cellular based and acts in a similar manner in all tissues...Vascepa limits injury due to ischemia (inadequate blood supply) something I have observed and can tell you it is very impressive..It also speed the reconstruction of tissues and this must be beneficial in the cardiovascular system...

I would stake every thing I own on R-I being successful and am convinced beyond all doubt this trial will exceed any of your expectations...

":>) JL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News